1,3-Oxazol-2(5H)-one → 3-{4-[4-(5-Cyclopropylpyridin-2-yl)piperazine-1-carbonyl]-3-fluorophenyl}oxazolidin-2-one
반응식
[Br:1][c:2]1[cH:3][c:4]([F:25])[c:5]([C:8](=[O:9])[N:10]2[CH2:11][CH2:12][N:13]([c:16]3[n:17][cH:18][c:19]([CH:22]4[CH2:23][CH2:24]4)[cH:20][cH:21]3)[CH2:14][CH2:15]2)[cH:6][cH:7]1.[O:26]1[C:27](=[O:31])[N:28]=[CH:29][CH2:30]1>>[c:2]1([N:28]2[C:27](=[O:31])[O:26][CH2:30][CH2:29]2)[cH:3][c:4]([F:25])[c:5]([C:8](=[O:9])[N:10]2[CH2:11][CH2:12][N:13]([c:16]3[n:17][cH:18][c:19]([CH:22]4[CH2:23][CH2:24]4)[cH:20][cH:21]3)[CH2:14][CH2:15]2)[cH:6][cH:7]1참가 물질
3
출처 및 근거
- ORD 기록
- ord-1cd8034de38a49f1852fbe8273d6069d
- 출처 데이터셋
- Training data from https://doi.org/10.1039/C8SC04228D (10/10)
반응 노트
불러오는 중…